Skip to main content
SpringerLink
Log in

Adalimumab

Aspiration pneumonia and lack of efficacy: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Liberman P, et al. Escalation to Weekly Adalimumab for the Treatment of Ocular Inflammation. Ocular Immunology and Inflammation 29: 1564-1568, No. 7, 17 Nov 2021. Available from: URL: http://doi.org/10.1080/09273948.2020.1749857

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1909, 21 (2022). https://doi.org/10.1007/s40278-022-16308-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-16308-2

Search

Navigation